170 Chapter 7 1. Colombo E, et al. Astrocytes: Key Regulators of Neuroinflammation. Trends Immunol. Sep 2016;37(9):608-620. doi:10.1016/j.it.2016.06.006 2. Gaudet AD, et al. Glial Cells Shape Pathology and Repair After Spinal Cord Injury. Neurotherapeutics. Jul 2018;15(3):554-577. doi:10.1007/s13311-0180630-7 3. Kiray H, et al. The multifaceted role of astrocytes in regulatingmyelination. ExpNeurol. Sep 2016;283(Pt B):541-9. doi:10.1016/j.expneurol.2016.03.009 4. Li J, et al. Astrocytes in Oligodendrocyte Lineage Development and White Matter Pathology. Front Cell Neurosci. 2016/05/10 2016;10:119. doi:10.3389/fncel.2016.00119 5. Seth P, et al. Astrocyte, the star avatar: redefined. J Biosci. Sep 2008;33(3):405-21. doi:10.1007/ s12038-008-0060-5 6. Orthmann-Murphy JL, et al. Gap junctions couple astrocytes and oligodendrocytes. journal article. J Mol Neurosci. May 2008;35(1):101-16. doi:10.1007/s12031-007-9027-5 7. McTigue DM, et al. The life, death, and replacement of oligodendrocytes in the adult CNS. J Neurochem. Oct 2008;107(1):1-19. doi:10.1111/j.14714159.2008.05570.x 8. Patel J, et al. Molecular mechanisms of oligodendrocyte injury in multiple sclerosis and experimental autoimmune encephalomyelitis. Int J Mol Sci. 2012/08/23 2012;13(8):10647-59. doi:10.3390/ijms130810647 9. Peferoen L, et al. Oligodendrocyte-microglia crosstalk in the central nervous system. Immunology. Mar 2014;141(3):302-13. doi:10.1111/imm.12163 10. van der Knaap MS, et al. Leukodystrophies: a proposedclassificationsystembasedonpathological changes and pathogenetic mechanisms. Acta Neuropathol. Sep 2017;134(3):351-382. doi:10.1007/s00401-017-1739-1 11. Bouchat J, et al. Regional oligodendrocytopathy and astrocytopathy precede myelin loss and blood-brain barrier disruption in a murine model of osmotic demyelination syndrome. Glia. Mar 2018;66(3):606-622. doi:10.1002/glia.23268 12. Gankam Kengne F, et al. Astrocytes are an early target in osmotic demyelination syndrome. Journal of the American Society of Nephrology : JASN. Oct 2011;22(10):1834-45. doi:10.1681/ ASN.2010111127 13. Gankam-Kengne F, et al. Osmotic Stress-Induced Defective Glial Proteostasis Contributes to Brain Demyelination after Hyponatremia Treatment. Journal of the American Society of Nephrology : JASN. Jun 2017;28(6):1802-1813. doi:10.1681/ ASN.2016050509 14. Coulter DA, et al. Astrocytic regulation of glutamate homeostasis in epilepsy. Glia. Aug 2012;60(8):121526. doi:10.1002/glia.22341 15. Seifert G, et al. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci. Mar 2006;7(3):194-206. doi:10.1038/ nrn1870 16. FaideauM, et al. Invivoexpressionof polyglutamineexpanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington’s disease subjects. HumMol Genet. Aug 1 2010;19(15):3053-67. doi:10.1093/hmg/ddq212 17. Simpson JE, et al. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging. Apr 2010;31(4):578-90. doi:10.1016/j.neurobiolaging.2008.05.015 18. Reich DS, et al. Multiple Sclerosis. N Engl J Med. Jan 11 2018;378(2):169-180. doi:10.1056/ NEJMra1401483 19. Thompson AJ, et al. Multiple sclerosis. The Lancet. 2018/04 2018;391(10130):1622-1636. doi:10.1016/s0140-6736(18)30481-1 20. Sloan SA, et al. Mechanisms of astrocyte development and their contributions to neurodevelopmental disorders. Curr Opin Neurobiol. Aug 2014;27:75-81. doi:10.1016/j. conb.2014.03.005 21. Zuchero JB, et al. Glia in mammalian development and disease. Development. Nov 15 2015;142(22):3805-9. doi:10.1242/dev.129304 22. Noble M, et al. Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury. Neurotherapeutics. Oct 2011;8(4):677-93. doi:10.1007/s13311-0110071-z 23. Domingues HS, et al. Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair. Front Cell Dev Biol. 2016/06/28 2016;4:71. doi:10.3389/fcell.2016.00071 24. Moore CS, et al. How factors secreted from astrocytes impact myelin repair. J Neurosci Res. Jan 2011;89(1):13-21. doi:10.1002/jnr.22482 25. Ponath G, et al. The Role of Astrocytes in Multiple Sclerosis. Front Immunol. 2018/02/19 2018;9:217. doi:10.3389/fimmu.2018.00217 26. Torkildsen O, et al. Disease-modifying treatments for multiple sclerosis - a review of approved medications. Eur J Neurol. Jan 2016;23 Suppl 1:1827. doi:10.1111/ene.12883 27. Hostenbach S, et al. Astrocyte loss and astrogliosis in neuroinflammatory disorders. Neurosci Lett. Apr 17 2014;565:39-41. doi:10.1016/j.neulet.2013.10.012 28. Popescu BF, et al. Pathology of demyelinating diseases. Annu Rev Pathol. 2012/02/28 2012;7(1):185-217. doi:10.1146/annurevpathol-011811-132443 29. Uzawa A, et al. Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6. Mult Scler. Dec 2010;16(12):144352. doi:10.1177/1352458510379247 References
RkJQdWJsaXNoZXIy MTk4NDMw